Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392821
Status:
COMPLETED
Last Update Posted:
2022-06-06
First Post:
2006-10-25
Brief Title:
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
Sponsor:
Organization:
SCRI Development Innovations LLC